Vytrus Biotech S.A. (VYT) — Capital Reinvestment Ratio
Vytrus Biotech S.A. (VYT) has a Capital Reinvestment Ratio of 2.19x as of December 2022, meaning it reinvests 2% of its operating cash flow (€225.55K) in capital expenditures (€494.16K). See Vytrus Biotech S.A. (VYT) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vytrus Biotech S.A. Capital Reinvestment Ratio (2021–2025)
This chart tracks Vytrus Biotech S.A.'s Capital Reinvestment Ratio across 5 annual periods. Check total reinvestment intensity of Vytrus Biotech S.A. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Vytrus Biotech S.A. (2021–2025)
Year-by-year Capital Reinvestment Ratio for Vytrus Biotech S.A. from 2021 to 2025. For live market cap and broader valuation context, see market value of Vytrus Biotech S.A..
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | €3.90 Million | €2.68 Million | ▲ +5.2% |
| 2024 | 0.65x | €1.84 Million | €1.20 Million | ▼ -49.4% |
| 2023 | 1.29x | €904.39K | €1.17 Million | ▼ -41.1% |
| 2022 | 2.19x | €225.55K | €494.16K | ▲ +261.0% |
| 2021 | 0.61x | €447.92K | €271.82K | — |